The deal adds to a growing biotech presence for Blackstone and supports testing of a drug competing with rival therapies from ...
Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...
AI could review data sets to assist clinical scientists ...
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
Platform to detect human-relevant insights for discovery and development of therapies for neurological diseases, ...
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are ...
The session Next-Generation Drug Development Enabled by Automation, Digitalization, and AI/ML is scheduled to take place at ...
Two weeks after Teva touted promising long-term data for its Sanofi-partnered bowel disease drug, the Israeli pharma ...
Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results